SEC Form 4 · accession 0001114220-18-000096
KERYX BIOPHARMACEUTICALS INC · KERX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A. Carberry
Officer — Chief Operating Officer
Period of report
Oct 18, 2018
Accepted (ET)
Oct 22, 2018 · 8:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 18, 2018 | S | 2,040 | $3.29 | D | 111,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of a total of 2,040 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 7,083 shares of restricted stock on October 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- F2Includes 76,665 shares of restricted stock.